Open Call SC1-BHC-20B-2020: Public Procurement of Innovative Solutions (PPI) for Diagnostics for Infectious Diseases

European CommissionImplementation of timely and correct diagnostics for infectious diseases (ID) that will speed up the identification of the causative infectious disease pathogens, possible drug resistances and drug susceptibility is crucial for tailoring the antimicrobial treatment, thus ensuring appropriate antimicrobial drug use. A combination of rapid, accurate and specific diagnostics and correct treatment promises not only to reduce caseloads of multi-drug resistant infections, but also to limit public spending for necessary isolation and hospitalisation by early and correctly identifying the appropriate treatment. In practice however, cost issues hamper the implementation of rapid diagnostics for ID in public health institutions, as innovative rapid diagnostics are still significantly more expensive than culture-based diagnostics. This issue and the lack of consideration of total cost of care limits the uptake of innovative rapid diagnostics in hospitals, which could result in a continued unspecific use of antimicrobials, prolonged hospitalisations and a non-patient centred provision of care.

Scope

This topic will contribute to the EU One Health Action Plan on Antimicrobial Resistance and should specifically consider the following:
  • Development of proposals for ‘Public Procurement of Innovative Solutions’ for the implementation of rapid diagnostic tools for infectious diseases in clinical practice. Proposals should be driven by clearly identified procurement needs of the participating organisations. In order to ensure compatibility and interoperability between infectious disease diagnostics and avoid technical/technology standardisation issues, public health procurers should also develop specifications that are applicable for EU-wide deployment of the innovative diagnostics.
  • Applications should be driven by public and/or private procurers from each participating country (at national, regional or local level) that have responsibilities and budget control in the relevant area of supply of health and care services. They should demonstrate the applicability of the ‘Most Economically Advantageous Tendering’ approach in cross-border collaboration of public procurers in the EU, defining specific outcome criteria of importance for patients well-being, and for innovation of public procurement in the area of infectious diseases and AMR, taking also into account overall economic and societal benefits, and sex and gender differences when relevant.
  • Proposals should include clear communication and outreach strategies aiming to actively promote and support public health procurement organisations and health care providers across regions and borders of the EU in adopting relevant innovation procurement approaches. They should specify measures that will ensure the sustainability of solutions beyond the lifespan of the proposed project.
  • Synergies with the Structural Reform Support Program and the European Structural and Investment Fund are encouraged.

Activities covered should include cooperation with policy makers to reinforce the national policy frameworks and mobilise substantial additional national budgets for PCP and PPI, searching support and collaborating with respective coordination and networking projects, e.g. PIPPI and HCO-12. Likewise, awareness raising, technical assistance and/or capacity building beyond the project to mainstream PPI implementation and removing obstacles for introducing the innovative solutions to be procured into the market could be included.

The Commission considers that proposals requesting a contribution from the EU of between EUR 3 and 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Specific requirements for PPI actions are described in part E of the General Annexes of the Work Programme.

Expected Impact

  • Implementation of innovative procurement practices for diagnostics for infectious diseases in the EU, based on the ‘most economically advantageous tendering' approach and involving newly acquired rapid diagnostic tests in hospital and ambulatory settings.
  • Contribute to the EU One Health Action Plan on Antimicrobial Resistance, in particular in relation to 'Better Prevention and Control of AMR' and the goal to address patient safety in hospital environments by supporting good practices in infection prevention and control.
  • Create new opportunities for market uptake and economies of scale for the supply side of rapid diagnostics in the area of respiratory tract infections across the EU.
  • Reduced fragmentation of demand for innovative solutions.

Opening date: 04 July 2019

Deadline: 07 April 2020 17:00:00 Brussels time

Deadline Model: single-stage

Type of action: Public Procurement of Innovative solutions (PPI)

For topic conditions, documents and submission service, please visit:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-bhc-20b-2020

PS: Find your partners or consortia preparing a project proposal
If you need help to identify a potential partner with particular competences, facilities or experience, please join and explore (HEALTH IT) SPACE www.healthitspace.eu.

Most Popular Now

AI can Detect COVID-19 in the Lungs Like…

A University of Central Florida researcher is part of a new study showing that artificial intelligence can be nearly as accurate as a physician in diagnosing COVID-19 in the lungs. The...

Liverpool John Moores University Gives S…

Liverpool John Moores University is to use Better's OPENeP electronic prescribing and medicines administration solution to teach nursing and pharmacy students about modern prescribing practices. The university and the company have...

Putting Virtual Rehab for Stroke Patient…

Researchers at the University of East Anglia have been putting virtual reality rehabilitation for stroke survivors to the test. They have created a new gaming platform which uses low cost...

An App Monitors Cancer Patients' Health …

Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using...

FDA Launches the Digital Health Center o…

Today, the U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the...

Tampa General Hospital Announces Strateg…

Tampa General Hospital (TGH) and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced they are creating a long-term strategic partnership designed to keep Tampa...

New Research Reveals Impact of COVID-19 …

Hospitals face new demand for virtual visiting, and more patients are confident they don't always need to see a doctor in person, as the use of remote technologies rise. But...

Black Country Pathology Services Deliver…

Black Country Pathology Services has pushed ahead with a major initiative to create a laboratory network to serve four trusts and delivered a successful go-live for its CliniSys laboratory information...

Highland Marketing Resilient through COV…

Highland Marketing, a full-service agency for health tech marketing, PR and communications, is recruiting three new account team members to support clients and growth. This is despite the economic and...

North Bristol NHS Clinicians Go Live in …

North Bristol NHS Trust has successfully and safely fast-tracked the roll out of a series of digital tools to clinicians to help in their response to COVID-19. Over 3,500 clinicians went...

Total Health: Build a Better Healthcare …

19 - 20 November, 2020. Digital Forum, #REhealthcare. The stage is set for a paradigm shift in healthcare. The opportunity exists to redefine healthcare in a way that transforms patient outcomes...

Telemedicine Saves Chronic Pain Patients…

Patients who saw a pain medicine specialist via telemedicine saved time and money and were highly satisfied with their experience, even before the COVID-19 pandemic, according to a study being...